SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M.A. Koenders, R. Saso, A mathematical model of cell equilibrium and joint cell formation in multiple myeloma, Journal of Theoretical Biology, 2016, 390, 73

    CrossRef

  2. 2
    David Laszlo Tarnoki, Adam Domonkos Tarnoki, Susanne Ohlmann-Knafo, Dirk Pickuth, Pattern of Tumour Spread of Common Primary Tumours as Seen on Magnetic Resonance Imaging, Pathology & Oncology Research, 2016, 22, 1, 79

    CrossRef

  3. 3
    J. Borggrefe, S. Giravent, G. Campbell, F. Thomsen, D. Chang, M. Franke, A. Günther, M. Heller, A. Wulff, Association of osteolytic lesions, bone mineral loss and trabecular sclerosis with prevalent vertebral fractures in patients with multiple myeloma, European Journal of Radiology, 2015, 84, 11, 2269

    CrossRef

  4. 4
    Jan Borggrefe, Sarah Giravent, Felix Thomsen, Jaime Peña, Graeme Campbell, Asmus Wulff, Andreas Günther, Martin Heller, Claus C Glüer, Association of QCT Bone Mineral Density and Bone Structure With Vertebral Fractures in Patients With Multiple Myeloma, Journal of Bone and Mineral Research, 2015, 30, 7
  5. 5
    M. Reyskens, K. Sleurs, L. Verresen, M. Janssen, J. van den Berg, P. Geusens, Hypophosphatemic osteomalacia: an unusual clinical presentation of multiple myeloma, Osteoporosis International, 2015, 26, 7, 2039

    CrossRef

  6. 6
    Faryal Mirza, Ernesto Canalis, MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management, European Journal of Endocrinology, 2015, 173, 3, R131

    CrossRef

  7. 7
    Max Markmiller, Percutaneous balloon kyphoplasty of malignant lesions of the spine: a prospective consecutive study in 115 patients, European Spine Journal, 2015, 24, 10, 2165

    CrossRef

  8. 8
    Roy Xiao, Jacob A. Miller, Konstantinos Margetis, Daniel Lubelski, Isador H. Lieberman, Edward C. Benzel, Thomas E. Mroz, Predicting the progression of vertebral fractures in patients with multiple myeloma, The Spine Journal, 2015,

    CrossRef

  9. 9
    Roy Xiao, Jacob A. Miller, Konstantinos Margetis, Daniel Lubelski, Isador H. Lieberman, Edward C. Benzel, Thomas E. Mroz, Radiographic progression of vertebral fractures in patients with multiple myeloma, The Spine Journal, 2015,

    CrossRef

  10. 10
    Jacob A. Miller, Andrew Bowen, Megan V. Morisada, Konstantinos Margetis, Daniel Lubelski, Isador H. Lieberman, Edward C. Benzel, Thomas E. Mroz, Radiologic and clinical characteristics of vertebral fractures in multiple myeloma, The Spine Journal, 2015, 15, 10, 2149

    CrossRef

  11. 11
    D.J. Bryson, L. Wicks, R.U. Ashford, The investigation and management of suspected malignant pathological fractures: A review for the general orthopaedic surgeon, Injury, 2015, 46, 10, 1891

    CrossRef

  12. 12
    Domenico Ribatti, Beatrice Nico, Angelo Vacca, 2015,

    CrossRef

  13. 13
    D. Hose, A. Seckinger, Biologie des multiplen Myeloms, Der Onkologe, 2014, 20, 3, 208

    CrossRef

  14. 14
    Evangelos Terpos, Nikolaos Kanellias, Krzysztof Giannopoulos, Biology and management of myeloma-related bone disease, Acta Haematologica Polonica, 2014, 45, 2, 107

    CrossRef

  15. 15
    R. Coleman, J. J. Body, M. Aapro, P. Hadji, J. Herrstedt, Bone health in cancer patients: ESMO Clinical Practice Guidelines, Annals of Oncology, 2014, 25, suppl 3, iii124

    CrossRef

  16. 16
    Lorenz C Hofbauer, Tilman D Rachner, Robert E Coleman, Franz Jakob, Endocrine aspects of bone metastases, The Lancet Diabetes & Endocrinology, 2014, 2, 6, 500

    CrossRef

  17. 17
    A. Seckinger, D. Hose, Interaktion zwischen Myelomzellen und Knochengewebe, Der Radiologe, 2014, 54, 6, 545

    CrossRef

  18. 18
    J.D. Stevenson, C. Wall, A. Patel, J. Lim, Multiple myeloma: a review, Orthopaedics and Trauma, 2014, 28, 3, 187

    CrossRef

  19. You have free access to this content19
    S L Webb, C M Edwards, Novel therapeutic targets in myeloma bone disease, British Journal of Pharmacology, 2014, 171, 16
  20. 20
    Sandrine P.G. Bours, Joop P.W. van den Bergh, Tineke A.C.M. van Geel, Piet P.M.M. Geusens, Secondary osteoporosis and metabolic bone disease in patients 50 years and older with osteoporosis or with a recent clinical fracture, Current Opinion in Rheumatology, 2014, 26, 4, 430

    CrossRef

  21. 21
    Sakshi Sikka, Muthu K. Shanmugam, Radhamani Kannaiyan, Rohit Surana, Eun Myoung Shin, Alan Prem Kumar, Gautam Sethi, Kwang Seok Ahn, Suppression of essential pro-inflammatory signaling pathways by natural agents for the therapy of Multiple Myeloma, Phytochemistry Reviews, 2014, 13, 1, 79

    CrossRef

  22. 22
    Matthew T Drake, Unveiling Skeletal Fragility in Patients Diagnosed With MGUS: No Longer a Condition of Undetermined Significance?, Journal of Bone and Mineral Research, 2014, 29, 12
  23. 23
    Bhasker Koppula, Justin Kaptuch, Christopher J. Hanrahan, Imaging of Multiple Myeloma: Usefulness of MRI and PET/CT, Seminars in Ultrasound, CT and MRI, 2013, 34, 6, 566

    CrossRef

  24. 24
    Natasha Ali, Bushra Moiz, Hira Silat, Anam Rehan, Salman Adil, Improved outcome of myeloma related bone pain with oral analgesics and bisphosphonate therapy: A single-center experience from Pakistan, Progress in Palliative Care, 2013, 21, 6, 337

    CrossRef

  25. 25
    Rebecca Silbermann, G. David Roodman, Myeloma bone disease: Pathophysiology and management, Journal of Bone Oncology, 2013, 2, 2, 59

    CrossRef

  26. 26
    Matthew T. Drake, Osteoporosis and Cancer, Current Osteoporosis Reports, 2013, 11, 3, 163

    CrossRef

  27. 27
    G. Sofía Oviedo, Osteoporosis secundaria. tratamiento actualizado, Revista Médica Clínica Las Condes, 2013, 24, 5, 805

    CrossRef

  28. 28
    Bujung Hong, Elvis J. Hermann, Christoph Reuter, Almuth Brandis, Joachim K. Krauss, Outcome of surgical decompression of spinal mass lesions in non-Hodgkin's lymphoma and plasmacytoma, Clinical Neurology and Neurosurgery, 2013, 115, 12, 2476

    CrossRef

  29. 29
    Susan Hudec, Pauline Camacho, Secondary Causes of Osteoporosis, Endocrine Practice, 2013, 19, 1, 120

    CrossRef

  30. 30
    E. Michael Lewiecki, Osteoporosis, 2013,

    CrossRef

  31. 31
    Rebecca Silbermann, G. David Roodman, Osteoporosis, 2013,

    CrossRef

  32. 32
    Qiang Li, Applying Stochastic Integer Programming to Optimization of Resource Scheduling in Cloud Computing, Journal of Networks, 2012, 7, 7

    CrossRef

  33. 33
    Deborah L Galson, Rebecca Silbermann, G David Roodman, Mechanisms of multiple myeloma bone disease, BoneKEy Reports, 2012, 1, 8

    CrossRef

  34. 34
    Karen Walker-Bone, Recognizing and treating secondary osteoporosis, Nature Reviews Rheumatology, 2012, 8, 8, 480

    CrossRef

  35. 35
    Vito Longo, Oronzo Brunetti, Stella D’Oronzo, Franco Dammacco, Franco Silvestris, Therapeutic approaches to myeloma bone disease: An evolving story, Cancer Treatment Reviews, 2012, 38, 6, 787

    CrossRef

  36. 36
    L. Caplan, A. E. Hines, E. Williams, A. V. Prochazka, K. G. Saag, F. Cunningham, E. Hutt, An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis, Osteoporosis International, 2011, 22, 1, 305

    CrossRef

  37. 37
    Alex R. Minter, Haley Simpson, Brendan M. Weiss, Ola Landgren, Bone Disease From Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: Pathogenesis, Interventions, and Future Opportunities, Seminars in Hematology, 2011, 48, 1, 55

    CrossRef

  38. 38
    Sigurdur Y Kristinsson, Alex R Minter, Neha Korde, Esther Tan, Ola Landgren, Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management, Expert Review of Molecular Diagnostics, 2011, 11, 6, 593

    CrossRef

  39. 39
    A. C. Ng, S. Khosla, N. Charatcharoenwitthaya, S. K. Kumar, S. J. Achenbach, M. F. Holets, L. K. McCready, L. J. Melton, R. A. Kyle, S. V. Rajkumar, M. T. Drake, Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1  levels in patients with MGUS, Blood, 2011, 118, 25, 6529

    CrossRef

  40. 40
    Michael Mulligan, Alin Chirindel, Michael Karchevsky, Characterizing and Predicting Pathologic Spine Fractures in Myeloma Patients With FDG PET/CT and MR Imaging, Cancer Investigation, 2011, 29, 5, 370

    CrossRef

  41. 41
    L Joseph Melton, Michael M Lieber, Elizabeth J Atkinson, Sara J Achenbach, Horst Zincke, Terry M Therneau, Sundeep Khosla, Fracture risk in men with prostate cancer: A population-based study, Journal of Bone and Mineral Research, 2011, 26, 8
  42. 42
    Teresa S. Miceli, Kathleen Colson, Beth M. Faiman, Kena Miller, Joseph D. Tariman, Maintaining Bone Health in Patients With Multiple Myeloma, Clinical Journal of Oncology Nursing, 2011, 15, 0, 9

    CrossRef

  43. 43
    N. Korde, S. Y. Kristinsson, O. Landgren, Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies, Blood, 2011, 117, 21, 5573

    CrossRef

  44. 44
    G. David Roodman, Osteoblast function in myeloma, Bone, 2011, 48, 1, 135

    CrossRef

  45. 45
    Dallas Jones, Laurie H. Glimcher, Antonios O. Aliprantis, Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection, Journal of Clinical Investigation, 2011, 121, 7, 2534

    CrossRef

  46. 46
    Stephen Schey, Karthik Ramasamy, Pomalidomide therapy for myeloma, Expert Opinion on Investigational Drugs, 2011, 20, 5, 691

    CrossRef

  47. 47
    Kelly L. Paul, Rehabilitation and Exercise Considerations in Hematologic Malignancies, American Journal of Physical Medicine & Rehabilitation, 2011, 90, Suppl 1, S88

    CrossRef

  48. 48
    Ping Wu, Gareth J. Morgan, Targeting Bone as a Therapy for Myeloma, Cancer Microenvironment, 2011, 4, 3, 299

    CrossRef

  49. 49
    L. C. Hofbauer, C. Hamann, P. R. Ebeling, Approach to the patient with secondary osteoporosis, European Journal of Endocrinology, 2010, 162, 6, 1009

    CrossRef

  50. 50
    Maurizio Zangari, Fenghuang Zhan, Guido Tricot, Bone and paraproteinemias, Current Opinion in Supportive and Palliative Care, 2010, 4, 3, 195

    CrossRef

  51. 51
    Allan Lipton, Bone Continuum of Cancer, Oncology Times, 2010, 32, Sup 1, S1

    CrossRef

  52. 52
    Allan Lipton, Bone Continuum of Cancer, American Journal of Clinical Oncology, 2010, 33, Supplement, S1

    CrossRef

  53. 53
    Béatrice Bouvard, Mathieu Royer, Daniel Chappard, Maurice Audran, Emmanuel Hoppé, Erick Legrand, Gammapathie monoclonale de signification indéterminée, myélome multiple et ostéoporose, Revue du Rhumatisme, 2010, 77, 2, 144

    CrossRef

  54. 54
    S. Y. Kristinsson, M. Tang, R. M. Pfeiffer, M. Bjorkholm, C. Blimark, U.-H. Mellqvist, A. Wahlin, I. Turesson, O. Landgren, Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study, Blood, 2010, 116, 15, 2651

    CrossRef

  55. 55
    Béatrice Bouvard, Mathieu Royer, Daniel Chappard, Maurice Audran, Emmanuel Hoppé, Erick Legrand, Monoclonal gammopathy of undetermined significance, multiple myeloma, and osteoporosis, Joint Bone Spine, 2010, 77, 2, 120

    CrossRef

  56. 56
    G. David Roodman, Pathogenesis of myeloma bone disease, Journal of Cellular Biochemistry, 2010, 109, 2
  57. 57
    G. David Roodman, Targeting the bone microenvironment in multiple myeloma, Journal of Bone and Mineral Metabolism, 2010, 28, 3, 244

    CrossRef

  58. 58
    Fergus E. McKiernan, Technetium-99m–Methyl Diphosphonate Bone Scintigraphy May Be Helpful in Preoperative Planning for Vertebroplasty in Multiple Myeloma: Two Cases, Journal of Vascular and Interventional Radiology, 2010, 21, 9, 1462

    CrossRef

  59. 59
    S. Vincent Rajkumar, Multiple Myeloma, Current Problems in Cancer, 2009, 33, 1, 7

    CrossRef

  60. 60
    Dimitrios Christoulas, Evangelos Terpos, Meletios A Dimopoulos, Pathogenesis and management of myeloma bone disease, Expert Review of Hematology, 2009, 2, 4, 385

    CrossRef

  61. 61
    G D Roodman, Pathogenesis of myeloma bone disease, Leukemia, 2009, 23, 3, 435

    CrossRef

  62. 62
    Jonathan M. Grasko, Richard P. Herrmann, Samuel D. Vasikaran, Recurrent Low-Energy Femoral Shaft Fractures and Osteonecrosis of the Jaw in a Case of Multiple Myeloma Treated With Bisphosphonates, Journal of Oral and Maxillofacial Surgery, 2009, 67, 3, 645

    CrossRef

  63. 63
    Jessica Levy, G. David Roodman, The role of bisphosphonates in multiple myeloma, Current Hematologic Malignancy Reports, 2009, 4, 2, 108

    CrossRef

  64. 64
    Kathleen Colson, Deborah S. Doss, Regina Swift, Joseph Tariman, Expanding Role of Bortezomib in Multiple Myeloma, Cancer Nursing, 2008, 31, 3, 239

    CrossRef

  65. 65
    Katherine A. McGlynn, Gloria Gridley, Lene Mellemkjaer, Louise A. Brinton, Kenneth C. Anderson, Neil E. Caporaso, Ola Landgren, Jorgen H. Olsen, Risks of cancer among a cohort of 23,935 men and women with osteoporosis, International Journal of Cancer, 2008, 122, 8
  66. 66
    G. D. Roodman, Skeletal Imaging and Management of Bone Disease, Hematology, 2008, 2008, 1, 313

    CrossRef

  67. 67
    Robert J. Oakland, Navin R. Furtado, Jake Timothy, Richard M. Hall, The biomechanics of vertebroplasty in multiple myeloma and metastatic bladder cancer: a preliminary cadaveric investigation, Journal of Neurosurgery: Spine, 2008, 9, 5, 493

    CrossRef

  68. 68
    AILLEEN HERAS-HERZIG, WENDE M. KOZLOW, SUE A. BROWN, THERESA A. GUISE, Osteoporosis, 2008,

    CrossRef

  69. 69
    The Bioarchaeology of Metabolic Bone Disease, 2008,

    CrossRef

  70. 70
    Jean-Jacques Body, Bisphosphonates in Advanced Malignant Disease, Clinical Reviews in Bone and Mineral Metabolism, 2007, 5, 3, 172

    CrossRef

  71. 71
    I von Metzler, H Krebbel, M Hecht, R A Manz, C Fleissner, M Mieth, M Kaiser, C Jakob, J Sterz, L Kleeberg, U Heider, O Sezer, Bortezomib inhibits human osteoclastogenesis, Leukemia, 2007, 21, 9, 2025

    CrossRef

  72. 72
    Sue A. Brown, Theresa A. Guise, Cancer-associated bone disease, Current Osteoporosis Reports, 2007, 5, 3, 120

    CrossRef

  73. 73
    Angela Dispenzieri, Complications of Myeloma Therapy, Hematology/Oncology Clinics of North America, 2007, 21, 6, 1247

    CrossRef

  74. 74
    D. Biau, P. Anract, Fractures sur os pathologique, EMC - Appareil locomoteur, 2007, 2, 4, 1

    CrossRef

  75. 75
    G D Roodman, Treatment strategies for bone disease, Bone Marrow Transplantation, 2007, 40, 12, 1139

    CrossRef

  76. 76
    Alissa Huston, G. David Roodman, Multiple Myeloma: Translational and Emerging Therapies, 2007,

    CrossRef

  77. 77
    Paul G Richardson, Constantine Mitsiades, Irene Ghobrial, Kenneth Anderson, Beyond single-agent bortezomib: combination regimens in relapsed multiple myeloma, Current Opinion in Oncology, 2006, 18, 6, 598

    CrossRef

  78. 78
    Ulrike Heider, Claudia Fleissner, Ivana Zavrski, Martin Kaiser, Monica Hecht, Christian Jakob, Orhan Sezer, Bone markers in multiple myeloma, European Journal of Cancer, 2006, 42, 11, 1544

    CrossRef

  79. 79
    Ulrike Heider, Martin Kaiser, Christian Müller, Christian Jakob, Ivana Zavrski, Carsten-Oliver Schulz, Claudia Fleissner, Monica Hecht, Orhan Sezer, Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment, European Journal of Haematology, 2006, 77, 3
  80. 80
    I. Sánchez del Campo, Fracturas patológicas en tumores primarios, Revista de Ortopedia y Traumatología, 2006, 50, 86

    CrossRef

  81. 81
    Henrik Gregersen, Paw Jensen, Mette Gislum, Birgit Jørgensen, Henrik Toft Sørensen, Mette Nørgaard, Fracture risk in patients with monoclonal gammopathy of undetermined significance, British Journal of Haematology, 2006, 135, 1
  82. 82
    Fedricker Diane Barber, Multiple Myeloma Early Recognition by Primary Care Nurse Practitioners, The Journal for Nurse Practitioners, 2006, 2, 10, 665

    CrossRef

  83. 83
    Howard S. Yeh, James R. Berenson, Myeloma bone disease and treatment options, European Journal of Cancer, 2006, 42, 11, 1554

    CrossRef

  84. 84
    Peter H. Wiernik, Plasma cell dyscrasias and leukemias, Update on Cancer Therapeutics, 2006, 1, 4, 539

    CrossRef

  85. 85
    Maurizio Zangari, Shmuel Yaccoby, Federica Cavallo, Dixie Esseltine, Guido Tricot, Response to Bortezomib and Activation of Osteoblasts in Multiple Myeloma, Clinical Lymphoma and Myeloma, 2006, 7, 2, 109

    CrossRef

  86. 86
    Alissa Huston, G David Roodman, Role of the microenvironment in multiple myeloma bone disease, Future Oncology, 2006, 2, 3, 371

    CrossRef

  87. 87
    Orhan Sezer, Myeloma bone disease, Hematology, 2005, 10, sup1, 19

    CrossRef

  88. 88
    Lawrence G. Raisz, Screening for Osteoporosis, New England Journal of Medicine, 2005, 353, 2, 164

    CrossRef

  89. 89
    Ronald C. Hamdy, Fracture Risk Assessment,
  90. 90
    Rebecca Silbermann, G. David Roodman, Hematologic Malignancies and Bone,
  91. 91
    Peter R. Ebeling, Secondary Causes of Osteoporosis: Bone Diseases,
  92. 92
    Jean-Jacques Body, Treatment and Prevention of Bone Metastases and Myeloma Bone Disease,